18 June 2026

Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product

Reference: CIR-2026-00000093

Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

Circular No. (25/2026)– Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product.pdf:

View Document